Donor scarcity is a major obstacle for clinical islet transplantation. Hence, the effective use of the limited number of available islets is necessary for successful islet transplantation. We have developed a new technology that could produce pseudo-islets. Morphologic and functional evaluation was performed to test the feasibility of using these cells for transplantation. A 3-step procedure known as disaggregation-expansion-reaggregation (DER) was employed for pseudo-islet preparation. Islets isolated from 200 to 250-g male Lewis rats by collagenase digestion were separated into single cells by trypsinization. These pancreatic endocrine cells (PECs) were expanded by serial passages in culture before being aggregated at a high cell-density ...
Background. Rejection and hypoxia are important factors causing islet loss at an early stage after p...
BACKGROUND: There is a widespread interest in developing renewable sources of islet-replacement tiss...
Introduction: To complement islet transplantation for type1 diabetic patients, cell-based therapy us...
Many obstacles beset islet transplantation, particularly insufficient tissue mass. Previously, we re...
Dept. of Medicine/박사Pancreas islet cell transplantation is a new therapy for type 1 diabetes mellitu...
Previously we demonstrated the superiority of small islets vs large islets in terms of function and ...
Clinical islet transplantation is a promising treatment for patients with type 1 diabetes. However, ...
A review is made of the relationship between the disease diabetes mellitus and the insulin-secreting...
β-Cell replacement through transplantation is the only curative treatment to establish a long-term s...
Pancreatic islet transplantation as a potential cure for type 1 diabetes (T1D) cannot be scaled up d...
The major obstacle in using pancreatic islet transplantation to cure type I and some type II diabete...
Transplantation of mature islets into portal vein has been most effective thus far, although attriti...
Diabetes mellitus is a high incidence disease that has increased rapidly in recent years. Many new t...
Transplantation of pancreatic islets isolated from organ donors constitutes a promising alternative ...
Abstract: The limited availability of human-donors makes the search for alternative islet sources ma...
Background. Rejection and hypoxia are important factors causing islet loss at an early stage after p...
BACKGROUND: There is a widespread interest in developing renewable sources of islet-replacement tiss...
Introduction: To complement islet transplantation for type1 diabetic patients, cell-based therapy us...
Many obstacles beset islet transplantation, particularly insufficient tissue mass. Previously, we re...
Dept. of Medicine/박사Pancreas islet cell transplantation is a new therapy for type 1 diabetes mellitu...
Previously we demonstrated the superiority of small islets vs large islets in terms of function and ...
Clinical islet transplantation is a promising treatment for patients with type 1 diabetes. However, ...
A review is made of the relationship between the disease diabetes mellitus and the insulin-secreting...
β-Cell replacement through transplantation is the only curative treatment to establish a long-term s...
Pancreatic islet transplantation as a potential cure for type 1 diabetes (T1D) cannot be scaled up d...
The major obstacle in using pancreatic islet transplantation to cure type I and some type II diabete...
Transplantation of mature islets into portal vein has been most effective thus far, although attriti...
Diabetes mellitus is a high incidence disease that has increased rapidly in recent years. Many new t...
Transplantation of pancreatic islets isolated from organ donors constitutes a promising alternative ...
Abstract: The limited availability of human-donors makes the search for alternative islet sources ma...
Background. Rejection and hypoxia are important factors causing islet loss at an early stage after p...
BACKGROUND: There is a widespread interest in developing renewable sources of islet-replacement tiss...
Introduction: To complement islet transplantation for type1 diabetic patients, cell-based therapy us...